2seventy bio, Inc.
TSVT
$9.98
$0.778.36%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/29/2023
-
Globe Newswire
3/29/2023
-
Ticker Report
3/28/2023
-
TipRanks Financial Blog
3/21/2023
-
Ticker Report
3/20/2023
-
Zolmax
3/19/2023
-
Simply Wall St
3/17/2023
-
Benzinga
3/17/2023
-
Benzinga
3/16/2023
-
Zacks Investment Research
3/16/2023
-
Business Wire
3/15/2023
-
Ticker Report
3/14/2023
-
Zolmax
3/9/2023
-
Zacks Investment Research
3/9/2023
-
SeekingAlpha
3/8/2023
-
Business Wire
3/6/2023
-
ETF Channel
3/5/2023
-
Ticker Report
3/3/2023
-
Business Wire
3/2/2023
-
Ticker Report
3/1/2023
-
Business Wire
2/28/2023
-
Seeking Alpha - Healthcare
2/28/2023
-
Business Wire
2/27/2023
-
Zolmax
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 16, 2023
Period Date
Saturday, December 31, 2022
Next Filing
Week of May 8 and 12 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
339 499 9300
Address
60 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company’s products pipeline...
more
